Marex Group’s Omega Healthcare OHI Stock Holding History

Marex Group’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,448	Closed	-$255K	–	737
2024 Q2	$255K	Buy	+7,448	New	+$235K	0.01%	450

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marex Group's OHI Position: Q3 2024 in Review

Marex Group sold out of Omega Healthcare (OHI) in Q3 2024, closing a stake of 7,448 shares — an estimated $255K sold.

Marex Group first reported a position in OHI in Q2 2024 and held it in 1 quarter. The position peaked at $255K in Q2 2024. 599 funds tracked by Wall St. Rank hold OHI as of Q3 2024.

Marex Group reported no remaining Omega Healthcare position as of Q3 2024 after selling out during the quarter.
Marex Group sold 7,448 Omega Healthcare shares in Q3 2024, an estimated $255K.
Marex Group first reported a position in Omega Healthcare in Q2 2024 and held it in 1 quarter.
Marex Group's Omega Healthcare position peaked at $255K in Q2 2024.
599 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2024.

Based on Marex Group's 13F filing for Q3 2024, filed 7 Apr 2026.